Mission:

Based in Zürich, Switzerland, Artonis strives to translate material science into cutting-edge products that deliver superior patient care and meet the needs of healthcare professionals and hospitals specialized in orthopedic care. Therefore, the spin-off Artonis AG seeks to develop and test novel solutions for hemostasis, spinal disc repair and cartilage regeneration.

Company structure:

Artonis AG is a “Balgrist Beteiligungs AG” (https://balgrist-beteiligungen.ch/aktuelle-beteiligungen). Further shareholders include the co-founders of the company, besides others. The companies headquarter is in Zürich. Cooperations include international key opinion leaders and leading med-tech industrial partners.

Governance:

Artonis operates in full compliance with the regulations of the Swiss Balgrist Association and the University of Zürich (UZH), where applicable. In particular, the handling of intellectual property is clearly defined and governed by the applicable policies and regulations. Furthermore, research collaborations and service activities are regulated either through mutual contractual agreements and/or through the valid institutional regulations of the respective organizations. Medical concepts under development by Artonis are in very early pre-clinical stage (proof of concept, in vitro and animal modelling). Medical Products of Artonis are not used at Balgrist University Hospital.